News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest coverage
30 headlines
Filed: 2026-08-27 AccNo: 0001996810-26-000153 Size: 144 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgarGap (NYSE:GAP) raises FY2026 Adj EPS guidance from $2.30-$2.40 to $2.35-$2.45 vs $2.34 analyst estimate. Narrows FY2026 sales outlook from $15.520 billion-$15.670 billion to $15.554 billion-$15.631 billion vs $15.531
Read original at benzingaGap Inc. (NYSE:GAP) today announced the appointment of Michael Francis as President and Chief Executive Officer of Old Navy, effective November 2, 2026. Francis will succeed Haio Barbeito, who will transition from his
Read original at benzingaFiled: 2026-08-27 AccNo: 0000737875-26-000031 Size: 156 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarFiled: 2026-08-27 AccNo: 0001193125-26-371317 Size: 142 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgarFiled: 2026-08-27 AccNo: 0001493152-26-040401 Size: 470 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Read original at edgarFiled: 2026-08-27 AccNo: 0001171843-26-005764 Size: 213 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarGap (NYSE:GAP) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.48 by 8.33 percent. This is a 8.77 percent decrease over earnings of $0.57 per share from the same period
Read original at benzingaBeginning with the opening of trading on September 1, 2026, the Company's Class A shares of no par value each (the "Class A Shares") will trade on the Nasdaq Capital Market on an adjusted basis, under the
Read original at benzingaLifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced due to the recent transition in the Chief
Read original at benzingahttps://www.sec.gov/Archives/edgar/data/1970544/000121390026094376/ea0302677-6k_itonic.htm
Read original at benzingaFiled: 2026-08-27 AccNo: 0001707753-26-000036 Size: 151 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarhttps://www.gevernova.com/news/press-releases/ge-vernova-announces-chief-financial-officer-transition
Read original at benzingaFiled: 2026-08-27 AccNo: 0001140361-26-034698 Size: 302 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 3.03: Material Modifications to Rights of Security Holders Item 5.01: Changes in Control of Registrant Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Read original at edgarLam Research (NASDAQ:LRCX) has outperformed the market over the past 20 years by 14.91% on an annualized basis producing an average annual return of 24.15%. Currently, Lam Research has a market capitalization of $398.65
Read original at benzingaFiled: 2026-08-27 AccNo: 0001193125-26-371310 Size: 280 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarPagerDuty (NYSE:PD) raises FY2027 Adj EPS guidance from $1.27-$1.32 to $1.33-$1.37 vs $1.32 analyst estimate. Raises FY2027 sales outlook from $488.500 million-$496.500 million to $491.500 million-$496.500 million vs
Read original at benzingaIM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press release dated August 18, 2026, the
Read original at benzingaFiled: 2026-08-27 AccNo: 0000106535-26-000009 Size: 46 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarFiled: 2026-08-27 AccNo: 0001493152-26-040398 Size: 237 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarAffirm expands its global partnership with Shopify to launch Shop Pay Installments in Australia. Powered exclusively by Affirm, it provides Australians the added flexibility to pay over time with no hidden fees, using
Read original at benzingaFiled: 2026-08-27 AccNo: 0001829126-26-009426 Size: 414 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarFiled: 2026-08-27 AccNo: 0001437749-26-029105 Size: 154 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgarFiled: 2026-08-27 AccNo: 0001437749-26-029104 Size: 9 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarFiled: 2026-08-27 AccNo: 0001193125-26-371309 Size: 167 KB Item 3.02: Unregistered Sales of Equity Securities
Read original at edgarFiled: 2026-08-27 AccNo: 0001869198-26-000049 Size: 134 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgarLiquidia (LQDA) and Insmed (INSM) are compared as commercial-stage biopharmaceutical companies focused on pulmonary hypertension treatments. LQDA shows impressive commercial momentum with Yutrepia generating $170.4M in Q2 sales and achieving four consecutive profitable quarters, but faces heavy reliance on a single product. INSM offers a more diversified portfolio with Brinsupri's strong launch ($1.25-$1.40B 2026 guidance) and established Arikayce revenue, plus a broader pipeline. While LQDA has outperformed INSM significantly this year (106.9% vs -28.5%), analysts recommend INSM as the more compelling long-term choice due to its diversified revenue base and sustainable growth story.
Read original at zacks-investment-researchCoherent Corp. (COHR) and AppLovin Corporation (APP) are both high-growth AI-focused technology companies. Coherent, which supports AI infrastructure through optical networking, shows stronger earnings momentum and faster expected growth (50% sales, 67% EPS) with a more attractive valuation. AppLovin's AI-powered advertising platform delivers superior margins and cash generation but faces downward earnings revisions and a richer valuation. Coherent receives a Zacks Rank #2 (Buy) while AppLovin holds Rank #3 (Hold).
Read original at zacks-investment-researchCerebras Systems and Advanced Micro Devices are both benefiting from AI infrastructure growth. While AMD offers greater scale, profitability and diversification with Data Center revenues more than doubling, Cerebras appears to have an edge with faster growth expectations, $25.4B in remaining performance obligations, and strong partnerships with OpenAI and AWS. Cerebras expects core revenues to more than triple in 2027, though it remains unprofitable with customer concentration risks.
Read original at zacks-investment-research